New Trends in Resuscitation

Current Problems in Surgery

Volumn 48, Issue 8, 2011, Pages 531-564

  Alam, Hasan B ^a,b   Velmahos, George C ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DIASPIRIN CROSSLINKED HEMOGLOBIN; DOPAMINE; FRESH FROZEN PLASMA; HISTONE DEACETYLASE INHIBITOR; HYPERTENSIVE AGENT; HYPERTENSIVE FACTOR; NALOXONE; NORADRENALIN; PHENYLEPHRINE; POLYMERIZED HEMOGLOBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOCYTE CONCENTRATE; VASOPRESSIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BLOODSTREAM INFECTION; BRAIN HEMORRHAGE; CELL DAMAGE; COMPARTMENT SYNDROME; CRYSTALLOID; ELECTROLYTE DISTURBANCE; EMERGENCY TREATMENT; ERYTHROCYTE CONCENTRATE; FLUID RESUSCITATION; HEART RATE; HEART STROKE VOLUME; HEMOPHILIA; HEMORRHAGIC SHOCK; HUMAN; HYPERLACTATEMIA; HYPOTENSION; HYPOVOLEMIC SHOCK; INTERMETHOD COMPARISON; LUNG EDEMA; MULTIPLE ORGAN FAILURE; NONHUMAN; OXYGEN CONSUMPTION; PATIENT SELECTION; PNEUMONIA; RESUSCITATION; SEPSIS; SEPTIC SHOCK; SIDE EFFECT; SPLANCHNIC BLOOD FLOW; SUBSTITUTION THERAPY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TACHYCARDIA; THROMBOCYTOPENIA; TRAUMATIC BRAIN INJURY; UNSPECIFIED SIDE EFFECT;

BLOOD TRANSFUSION; CARDIOPULMONARY RESUSCITATION; CARDIOVASCULAR AGENTS; FLUID THERAPY; HEMORRHAGE; HUMANS; UNITED STATES; WOUNDS AND INJURIES;

EID: 79959661903     PISSN: 00113840     EISSN: 15356337     Source Type: Journal    
DOI: 10.1067/j.cpsurg.2011.04.002     Document Type: Article

References (179)

1. National Center for Injury Prevention and Control. In: Web-Based Injury Statistics Query and Reporting System (WISQARS) Centers for Disease Control and Prevention, Accessed November 18, 2010. http://www.cdc.gov/ncipc/wisqars.
2. Finkelstein E.A., Corso P.S., Miller T.R. Incidence and Economic Burden of Injuries in the United States 2006, Associates, Oxford University Press, New York.
3. Baker C.C., Oppenheimer L., Stephens B., et al. Epidemiology of trauma deaths. Am J Surg 1980, 140:144-150.
4. Trunkey D.D., Blaisdell F.W. Epidemiology of trauma. Sci Am 1988, 4:1.
5. Shackford S.R., Mackersie R.C., Holbrook T.L., et al. The epidemiology of traumatic death. A population-based analysis. Arch Surg 1993, 128:571-575.
6. Sauaia A., Moore F.A., Moore E.E., et al. Epidemiology of trauma deaths: a reassessment. J Trauma 1995, 38:185-193.
7. Acosta J.A., Yang J.C., Winchell R.J., et al. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg 1998, 186:528-533.
8. Santry H.P., Alam H.B. Fluid resuscitation: Past, present, and the future. Shock 2010, 33:229-241.
9. Kaweski S.M., Sise M.J., Virgilio R.W. The effect of prehospital fluids on survival in trauma patients. J Trauma 1990, 30:1215-1218.
10. Turner J., Nicholl J., Webber L., et al. A randomised controlled trial of prehospital intravenous fluid replacement therapy in serious trauma. Health Technol Assess 2000, 4:1-57.
11. Greaves M.W., Hussein S.H. Fluid resuscitation in pre-hospital trauma care: a consensus view. J R Coll Surg Edinb 2002, 47:451-457.
12. Dula D.J., Wood G.C., Rejmer A.R., et al. Use of prehospital fluids in hypotensive blunt trauma patients. Prehosp Emerg Care 2002, 6:417-420.
13. Dutton R.P., Mackenzie C.F., Scalea T.M. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma 2002, 52:1141-1146.
14. Cannon W.B., Faser J., Collew E.M. The preventive treatment of wound shock. JAMA 1918, 47:618.
15. Shires G.T., Carrico C.J., Baxter C.R., et al. Principles in treatment of severely injured patients. Adv Surg 1970, 4:255-324.
16. Shires T., Coln D., Carrico J., et al. Fluid therapy in hemorrhagic shock. Arch Surg 1964, 88:688-693.
17. Dillon J., Lunch L.J., Myers R., et al. A bioassay of treatment of hemorrhagic shock. Arch Surg 1966, 93:537-555.
18. Cervera A.L., Moss G. Progressive hypovolemia leading to shock after continuous hemorrhage and 3:1 crystalloid replacement. Am J Surg 1975, 129:670-674.
19. Shoemaker W.C., Appel P.L., Kram H.B., et al. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988, 94:1176-1186.
20. Bishop M.H., Shoemaker W.C., Appel P.L., et al. Prospective, randomized trial of survivor values of cardiac index, oxygen delivery, and oxygen consumption as resuscitation endpoints in severe trauma. J Trauma 1995, 38:780-787.
21. Lobo S.M., Lobo F.R., Polachini C.A., et al. Prospective, randomized trial comparing fluids and dobutamine optimization of oxygen delivery in high-risk surgical patients [ISRCTN42445141]. Crit Care 2006, 10:R72.
22. McKinley B.A., Kozar R.A., Cocanour C.S., et al. Normal versus supranormal oxygen delivery goals in shock resuscitation: the response is the same. J Trauma 2002, 53:825-832.
23. Velmahos G.C., Demetriades D., Shoemaker W.C., et al. Endpoints of resuscitation of critically injured patients: normal or supranormal?. A prospective randomized trial. Ann Surg 2000, 232:409-418.
24. Marr A.B., Moore F.A., Sailors R.M., et al. Preload optimization using "starling curve" generation during shock resuscitation: Can it be done?. Shock 2004, 21:300-305.
25. Yu M., Levy M.M., Smith P., et al. Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study. Crit Care Med 1993, 21:830-838.
26. Durham R.M., Neunaber K., Mazuski J.E., et al. The use of oxygen consumption and delivery as endpoints for resuscitation in critically ill patients. J Trauma 1996, 41:32-39.
27. Kirkpatrick A.W., Balogh Z., Ball C.G., et al. The secondary abdominal compartment syndrome: iatrogenic or unavoidable?. J Am Coll Surg 2006, 202:668-679.
28. Balogh Z., McKinley B.A., Cocanour C.S., et al. Supranormal trauma resuscitation causes more cases of abdominal compartment syndrome. Arch Surg 2003, 138:637-642.
29. Pruitt B.A. Protection from excessive resuscitation: "Pushing the pendulum back.". J Truama 2000, 49:567-568.
30. Stern S.A., Dronen S.C., Birrer P., et al. Effect of blood pressure on hemorrhage volume and survival in a near-fatal hemorrhage model incorporating a vascular injury. Ann Emerg Med 1993, 22:155-163.
31. Selby J.B., Mathis J.E., Berry C.F., et al. Effects of isotonic saline solution resuscitation on blood coagulation in uncontrolled hemorrhage. Surgery 1996, 119:528-533.
32. Sondeen J.L., Coppes V.G., Holcomb Blood pressure at which rebleeding occurs after resuscitation in swine with aortic injury. J Trauma 2003, 54(suppl):S100-S107.
33. Rotondo M.F., Schwab C.W., McGonigal M.D., et al. "Damage Control": an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma 1993, 35:375-383.
34. Mapstone J., Roberts I., Evans P. Fluid resuscitation strategies: a systematic review of animal trials. J Trauma 2003, 55:571-589.
35. Liberman M., Mulder D., Sampalis J. Advanced or basic life support for trauma: meta-analysis and critical review of the literature. J Trauma 2000, 49:584-599.
36. Bickel W.H., Wall M.J., Pepe P.E., et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994, 331:1105-1109.
37. Kwan I., Bunn F., Roberts I., et al. Timing and volume of fluid administration for patients with bleeding. Cochrane Database Syst Rev 2003, 3:CD002245.
38. Alam H.B. An update on fluid resuscitation. Scand J Surg 2006, 95:136-145.
39. Fluid Resuscitation: State of the Science for Treating Combat Casualties and Civilian Trauma. Report of the Institute of Medicine 1999, Committee on fluid resuscitation for combat casualties, National Academies Press, Washington, DC.
40. Alam H.B., Rhee P. New developments in fluid resuscitation. Surg Clin North Am 2007, 87:55-72.
41. Cotton B.A., Guy J.S., Morris J.A., et al. The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock 2006, 26:115-121.
42. Daugherty E.L., Hongyan L., Taichman D., et al. Abdominal compartment syndrome is common in medical intensive care unit patients receiving large volume resuscitation. J Intensive Care Med 2007, 22:294-299.
43. O'Mara M.S., Slater H., Goldfarb I.W., et al. A prospective, randomized evaluation of intra-abdominal pressures with crystalloid and colloid resuscitation in burn patients. J Trauma 2005, 58:1011-1018.
44. Balogh Z., Moore F.A., Moore E.E., et al. Secondary abdominal compartment syndrome: a potential threat for all trauma clinicians. Injury 2007, 38:272-279.
45. Klein M.B., Hayden D., Elson C., et al. The association between fluid administration and outcome following major burn: A multicenter study. Ann Surg 2007, 245:622-628.
46. Combat Fluid Resuscitation 2001, Uniformed Services University of the Health Sciences, Department of Surgery; Department of Military and Emergency Medicine, Sponsored by US Office of Naval Research; US Army Medical Research and Material Command Bethesda, MD.
47. Fluid Resuscitation in Combat 2001, Defense and Civil Institute of Environmental Medicine, Defense and Civil Institute of Environmental Medicine, Department of Surgery, University of Toronto and the Office of Naval Research, Sponsored by Defense R and D Canada Toronto, Ontario.
48. Champion H.R. Combat fluid resuscitation: Introduction and overview of conferences. J Trauma 2003, 54(suppl):7-12.
49. Rhee P., Koustova E., Alam H.B. Searching for the optimal resuscitation method: recommendations for the initial fluid resuscitation of combat casualties. J Trauma 2003, 54(suppl):52-62.
50. Gwande A. Casualties of war-Military care for the wounded from Iraq and Afghanistan. N Engl J Med 2004, 351:2471-2475.
51. Varela J.E., Cohn S.M., Diaz I., et al. Splanchnic perfusion during delayed, hypotensive, or aggressive fluid resuscitation from uncontrolled hemorrhage. Shock 2003, 20:476-480.
52. Lu Y.Q., Cai X.J., Gu L.H., et al. Experimental study of controlled fluid resuscitation in the treatment of severe and uncontrolled hemorrhagic shock. J Trauma 2007, 63:798-804.
53. Xiao N., Wang X.C., Diao Y.F., et al. Effect of initial fluid resuscitation on subsequent treatment in uncontrolled hemorrhagic shock in rats. Shock 2004, 21:276-280.
54. Skarda D.E., Mulier K.E., George M.E., et al. Eight hours of hypotensive versus normotensive resuscitation in a porcine model of controlled hemorrhagic shock. Acad Emerg Med 2008, 15:845-852.
55. Rafie A.D., Rath P.A., Michell M.W., et al. Hypotensive resuscitation of multiple hemorrhages using crystalloid and colloids. Shock 2004, 22:262-269.
56. Haas B., Nathens A.B. Pro/con debate: Is the scoop and run approach the best approach to trauma services organization?. Crit Care 2008, 12:224-235.
57. Rivers E., Nguyen B., Havstad S., et al. Early goal directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377. Early Goal-Directed Therapy Collaborative Group.
58. Hollenberg S.M., Ahrens T.S., Annane D., et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 2004, 32:1928-1948.
59. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.
60. LeDoux D., Astiz M.E., Carpati C.M., et al. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000, 28:2729-2732.
61. Müllner M., Urbanek B., Havel C., et al. Vasopressors for shock. Cochrane Database Syst Rev 2004, 3. CD003709.
62. Russell J.A. Vasopressin in vasodilatory and septic shock. Curr Opin Crit Care 2007, 13:383-391.
63. Russell J.A., Walley K.R., Singer J., et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358:877-887.
64. Morales D., Madigan J., Cullinane S., et al. Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 1999, 100:226-229.
65. Sanui M., King D.R., Feinstein A.J., et al. Effects of arginine vasopressin during resuscitation from hemorrhagic hypotension after traumatic brain injury. Crit Care Med 2006, 34:433-438.
66. Voelckel W.G., Raedler C., Wenzel V., et al. Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs. Crit Care Med 2003, 31:1160-1165.
67. Voelckel W.G., Convertino V.A., Lurie K.G., et al. Vasopressin for hemorrhagic shock management: revisiting the potential value in civilian and combat casualty care. J Trauma 2010, 69(suppl 1):S69-S74.
68. Sperry J.L., Minei J.P., Frankel H.L., et al. Early use of vasopressors after injury: Caution before constriction. J Trauma 2008, 64:9-14.
69. Holcomb J.B., Jenkins D., Rhee P., et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007, 62:307-310.
70. Alam H.B., Bice L.M., Butt M.U., et al. Testing of blood products in a polytrauma model: Results of a Multi-Institutional Randomized Preclinical Trial. J Trauma 2009, 67:856-864.
71. Levy J.H., Dutton R.P., Hemphill J.C., et al. Multidisciplinary approach to the challenge of hemostasis. Anesth Analg 2010, 110:354-364.
72. Gonzales E.A., Moore F.A., Holcomb J.B., et al. Fresh frozen plasma should be given earlier to patients receiving massive transfusion. J Trauma 2007, 62:112-119.
73. Borgman M.A., Spinella P.C., Perkins J.G., et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007, 63:805-813.
74. Duchesne J.C., Hunt J.P., Wahl G., et al. Review of current blood transfusions strategies in a mature level I trauma center: Were we wrong for the last 60 years?. J Trauma 2008, 65:272-276.
75. Holcomb J.B., Wade C.E., Michalek J.E., et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008, 248:447-458.
76. Inaba K., Lustenberger T., Rhee P., et al. The impact of platelet transfusion in massively transfused trauma patients. J Am Coll Surg 2010, 211:573-579.
77. Snyder C.W., Weinberg J.A., McGwin G., et al. The relationship of blood product ratio to mortality: Survival benefit or survival bias?. J Trauma 2009, 66:358-362.
78. Inaba K., Branco B.C., Rhee P., et al. Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg 2010, 210:957-965.
79. Inaba K., Branco B.C., Rhee P., et al. Impact of ABO-identical vs ABO-compatible nonidentical plasma transfusion in trauma patients. Arch Surg 2010, 145:899-906.
80. Malone D.L., Hess J.R., Fingerhut A. Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol. J Trauma 2006, 60:S91-S96.
81. Cotton B.A., Gunter O.L., Isbell J., et al. Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma 2008, 64:1177-1182.
82. Dente C.J., Shaz B.H., Nicholas J.M., et al. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma 2009, 66:1616-1624.
83. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350:2247-2256. SAFE Study Investigators.
84. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007, 357:874-884. The SAFE Study Investigators.
85. Silliman C.C., Moore E.E., Johnson J.L., et al. Transfusion of the injured patient: proceed with caution. Shock 2004, 21:291-299.
86. Charles A., Shaikh A.A., Walters M., et al. Blood transfusion is an independent predictor of mortality after blunt trauma. Am Surg 2007, 73:1-5.
87. Offner P.J., Moore E.E., Biffl W.L., et al. Increased rate of infection associated with transfusion of old blood after severe injury. Arch Surg 2002, 137:711-717.
88. Dunne J.R., Malone D.L., Tracy J.K., et al. Allogenic blood transfusion in the first 24 hours after trauma is associated with increased systemic inflammatory response syndrome (SIRS) and death. Surg Infect (Larchmt) 2004, 5:395-404.
89. Moore F.A., Moore E.E., Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg 1997, 132:620-624.
90. Moore E.E. Blood substitutes: the future is now. J Am Coll Surg 2003, 196:1-17.
91. Sloan E.P., Koenigsberg M., Gens D., et al. Diaspirin cross-linked hemoglobin (dclhb) in the treatment of severe traumatic hemorrhagic shock: A randomized controlled efficacy trial. JAMA 1999, 282:1857-1864.
92. Kerner T., Ahlers O., Veit S., et al. DCL-Hb for trauma patients with severe hemorrhagic shock: The European "On-Scene" multicenter study. Intensive Care Med 2003, 29:378-385.
93. Moore E.E., Moore F.A., Fabian T.C., et al. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg 2009, 208:1-13.
94. Natanson C., Kern S.J., Lurie P., et al. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: A meta-analysis. JAMA 2008, 299:2304-2312.
95. Accessed October 3, 2010. http://clinicaltrials.gov/ct2/show/NCT00301483?term=HBOC201%26rank=1.
96. Jahr J.S., Mackenzie C., Pearce L.B., et al. HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery. J Trauma 2008, 64:1484-1497.
97. Boffard K.D., Riou B., Warren B., et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005, 59:8-15.
98. Hauser C.J., Boffard K., Dutton R., et al. Results of the CONTROL trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage. J Trauma 2010, 69:489-500.
99. Lin Y., Stanworth S., Birchall J., et al. Use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysis. CMAJ 2011, 183(1):E9-E19.
100. Wade C.E., Eastridge B.J., Jones J.A., et al. Use of recombinant factor VIIa in US military casualties for a five-year period. J Trauma 2010, 69:353-359.
101. Mayer S.A., Brun N.C., Begtrup K., et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008, 358:2127-2137.
102. O'Connell K.A., Wood J.J., Wise R.P., et al. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 2006, 18:293-298.
103. Narayan R.K., Maas A.I., Marshall L.F., et al. Recombinant factor VIIA in traumatic intracerebral hemorrhage: Results of a dose-escalation clinical trial. Neurosurgery 2008, 62:776-786.
104. Perel P., Roberts I., Shakur H., et al. Haemostatic drugs for traumatic brain injury. Cochrane Database Syst Rev 2010, 1:CD007877.
105. Leissinger C.A., Blatt P.M., Hoots W.K., et al. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol 2008, 83:137-143.
106. Schick K.S., Fertmann J.M., Jauch K.W., et al. Prothrombin complex concentrate in surgical patients: Retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding. Crit Care 2009, 13:R191.
107. Bernstein B.E., Meissner A., Lander E.S. The mammalian epigenome. Cell 2007, 128:669-681.
108. Goldberg A.D., Allis C.D., Bernstein E. Epigenetics: a landscape takes shape. Cell 2007, 128;:635-638.
109. Yu H.P., Chaudry I.H. The role of estrogen and receptor agonists in maintaining organ function after trauma-hemorrhage. Shock 2009, 31:227-237.
110. Deree J., Martins J., de Campos T., et al. Pentoxifylline attenuates lung injury and modulates transcription factor activity in hemorrhagic shock. J Surg Res 2007, 143:99-108.
111. Boeuf B., Poirier V., Gauvin F., et al. Naloxone for shock. Cochrane Database Syst Rev 2003, CD004443.
112. Lin T., Alam H.B., Chen H., et al. Cardiac histones are substrates of histone deacetylase activity in hemorrhagic shock and resuscitation. Surgery 2006, 139:365-376.
113. Alam H.B., Shults C., Ahuja N., et al. Impact of resuscitation strategies on the acetylation status of cardiac histones in a swine model of hemorrhage. Resuscitation 2008, 76:299-310.
114. Gonzales E.R., Chen H., Munuve R.M., et al. Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock. J Trauma 2008, 65:554-565.
115. Shults C., Sailhamer E.A., Li Y., et al. Surviving blood loss without fluid resuscitation. J Trauma 2008, 64:629-638.
116. Alam H.B., Shuja F., Butt M.U., et al. Surviving blood loss without blood transfusion in a swine poly-trauma model. Surgery 2009, 146:325-333.
117. Sailhamer E.A., Li Y., Smith E.J., et al. Acetylation: A novel method for modulation of the immune response following trauma/hemorrhage and inflammatory second hit in animals and humans. Surgery 2008, 144:204-216.
118. Li Y., Yuan Z., Liu B., et al. Prevention of hypoxia-induced neuronal apoptosis through histone deacetylase inhibition. J Trauma 2008, 64:863-870.
119. Li Y., Liu B., Sailhamer E.A., et al. Cell protective mechanism of valproic acid in lethal hemorrhagic shock. Surgery 2008, 144:217-224.
120. Butt M.U., Sailhamer E., Li Y., et al. Pharmacologic resuscitation: Cell protective mechanisms of histone deacetylase inhibition in lethal hemorrhagic shock. J Surg Res 2009, 156:290-296.
121. Li Y., Liu B., Zhao H., et al. Protective effect of suberoylanilide hydroxamic acid against LPS-induced septic shock in rodents. Shock 2009, 146:325-333.
122. Li Y., Alam H.B. Modulation of acetylation: creating a pro-survival and anti-inflammatory phenotype in lethal hemorrhagic and septic shock. J Biomed Biotechnol 2011, 2011. 523481.
123. Tisherman S.A., Safar P., Radovsky A., et al. Therapeutic deep hypothermic circulatory arrest in dogs: A resuscitation modality for hemorrhagic shock with. J Trauma 1990, 30:836-847.
124. Tisherman S.A., Safar P., Radovsky A., et al. Profound hypothermia (<10C) compared with deep hypothermia (15C) improves neurologic outcome in dogs after two hours circulatory arrest induced to enable resuscitative surgery. J Trauma 1991, 31:1051-1062.
125. Capone A., Safar P., Radovsky A., et al. Complete recovery after normothermic hemorrhagic shock and profound hypothermic circulatory arrest of 60 minutes in dogs. J Trauma 1996, 40:388-395.
126. Behringer W., Prueckner S., Kentner R., et al. Rapid hypothermic aortic flush can achieve survival without brain damage after 30 minutes cardiac arrest in dogs. Anesthesiology 2000, 93:1491-1499.
127. Behringer W., Safar P., Wu X., et al. Survival without brain damage after clinical death of 60-120 mins in dogs using suspended animation by profound hypothermia. Crit Care Med 2003, 31:1523-1531.
128. Taylor M.J., Bailes J.E., Elrifai A.M., et al. A new solution for life without blood. Asanguineous low-flow perfusion of a whole-body perfusate during 3 hours of cardiac arrest and profound hypothermia. Circulation 1995, 91:431-444.
129. Rhee P., Talon E., Eifert S., et al. Induced hypothermia during emergency department thoracotomy: an animal model. J Trauma 1999, 48:439-449.
130. Alam H.B., Bowyer M.W., Koustova E., et al. Learning and memory is preserved after induced asanguineous hyperkalemic hypothermic arrest in a swine model of traumatic exsanguination. Surgery 2002, 132:278-288.
131. Alam H.B., Chen Z., Honma K., et al. The rate of induction of hypothermic arrest determines the outcome in a swine model of lethal hemorrhage. J Trauma 2004, 57:961-969.
132. Alam H.B., Rhee P., Honma K., et al. Does the rate of rewarming from profound hypothermic arrest influence the outcome in a swine model of lethal hemorrhage?. J Trauma 2006, 60:134-146.
133. Chen Z., Chen H., Rhee P., et al. Induction of profound hypothermia modulates the immune/inflammatory response in a swine model of lethal hemorrhage. Resuscitation 2005, 66:209-216.
134. Alam H.B., Chen Z., Ahuja N., et al. Profound hypothermia protects neurons and astrocytes, and preserves cognitive functions in a Swine model of lethal hemorrhage. J Surg Res 2005, 126:172-181.
135. Shuja F., Tabbara M., Li Y., et al. Profound hypothermia decreases cardiac apoptosis through Akt survival pathway. J Am Coll Surg 2009, 209:89-99.
136. Alam H.B., Chen Z., Li Y., et al. Profound hypothermia is superior to ultraprofound hypothermia in improving survival in a swine model of lethal injuries. Surgery 2006, 140:307-314.
137. Alam H.B., Duggan M., Li Y., et al. Putting life on hold-for how long?. Profound hypothermic cardiopulmonary bypass in a Swine model of complex vascular injuries. J Trauma 2008, 64:912-922.
138. Sailhamer E.A., Chen Z., Ahuja N., et al. Profound hypothermic cardiopulmonary bypass facilitates survival without a high complication rate in a swine model of complex vascular, splenic, and colon injuries. J Am Coll Surg 2007, 204:642-653.
139. Casas F., Alam H., Reeves A., et al. A suspended animation forward lines casualty management system. Artif Organs 2005, 29:557-563.
140. Taylor M.J., Rhee P., Chen Z., et al. Design of preservation solutions for universal tissue preservation in vivo: Demonstration of efficacy in preclinical models of profound hypothermic cardiac arrest. Transplant Proc 2005, 37:303-307.
141. Kheirbek T., Kochanek A.R., Alam H.B. Hypothermia in bleeding trauma: a friend or a foe?. Scand J Trauma Resusc Emerg Med 2009, 17:65.
142. Alam H.B., Hashmi S., Finkelstein R.A., et al. Alterations in gene expression after induction of profound hypothermia for the treatment of lethal hemorrhage. J Trauma 2010, 68:1084-1098.
143. Blackstone E., Morrison M., Roth M.B. H2S induces a suspended animation-like state in mice. Science 2005, 308:518.
144. Fukudome E.Y., Alam H.B. Hypothermia in multisystem trauma. Crit Care Med 2009, 37(suppl):S265-S272.
145. Accessed May 4, 2010. http://clinicaltrials.gov/ct2/show/NCT01042015?term=EPR%26rank=2.
146. Kauvar D.S., Holcomb J.B., Norris G.C., et al. Fresh whole blood transfusion: A controversial military practice. J Trauma 2006, 61:181-184.
147. Johnson V.V., Swiatkowski S.A. Scientific aspects of supplying blood to distant military theaters. Curr Opin Hematol 2007, 14:694-699.
148. Oktavec W.A., Smetana E.J. Lyophilized normal human plasma control in the prothrombin-time clotting test. Am J Clin Pathol 1954, 24:250.
149. Oberman H.A., Barnes B.A., Ginther P.L. Erythrocyte sensitization and anemia due to isoantibodies in lyophilized pooled plasma. JAMA 1966, 198:323-325.
150. Krutvacho T., Chuansumrit A., Isarangkura P., et al. Response of hemophilia A with bleeding to fresh dry plasma. Southeast Asian J Trop Med Public Health 1993, 24(suppl 1):169.
151. Dombrose F.A., Barnes C.C., Gaynor J.J., et al. A lyophilized human reference plasma for coagulation factors. Evidence for Stability Factors II, V, and VII through XII. Am J Clin Pathol 1982, 77:32-45.
152. Ramsey R.B., Evatt B.L., McDougal J.S., et al. Antibody to human immunodeficiency virus in factor-deficient plasma. Effect of heat treatment on lyophilized plasma. Am J Clin Pathol 1987, 87:263-266.
153. Fu P., Myhre B. Chemical analysis of a 30-year-old bottle of lyophilized plasma. Transfusion 1977, 17:32-45.
154. Redeker A.G., Hopkins C.E., Jackson B., et al. A controlled study of the safety of pooled plasma stored in the liquid state at 30-32 C for six months. Transfusion 1968, 8:60-64.
155. Stramer S.L., Glynn S.A., Kleinman S.H., et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004, 35:760-768.
156. Hellstern P., Sachse H., Schwinn H., et al. Manufacture and in vitro characterization of a solvent/detergent-treated human plasma. Vox Sang 1992, 63:178-185.
157. Shuja F., Shults C., Duggan M., et al. Development and testing of freeze dried plasma for the treatment of trauma associated coagulopathy. J Trauma 2008, 65:975-985.
158. Spoerke N., Zink K., Cho S.D., et al. Lyophilized plasma for resuscitation in a swine model of severe injury. Arch Surg 2009, 144:829-834.
159. Wong Y.L., Sampson S., Germishuizen W.A., et al. Drying a tuberculosis vaccine without freezing. Proc Natl Acad Sci U S A 2007, 104:2591-2595.
160. Shuja F., Finkelstein R.A., Fukudome E.Y., et al. Development and testing of low volume hypertonic, hyperoncotic spray dried plasma for the treatment of trauma-associated coagulopathy. J Trauma 2011, 70:664-671.
161. Barrows E. Freeze dried plasma: the trail back to the battlefield. Defense L 2006;16-19 Accessed May 10, 2010. http://www.dau.mil/pubscats/PubsCats/atl/2006_09_10/bar_so_06.pdf.
162. Blajchman M.A. Substitutes and alternatives to platelet transfusions in thrombocytopenic patients. J Thrombosis Haemostasis 2003, 1:1637-1641.
163. Bode A.P., Fischer T.H. Lyophilized platelets: fifty years in the making. Artif Cells Blood Substit Immobil Biotechnol 2007, 35:125-133.
164. Read M.S., Reddick R.L., Bode A.P., et al. Preservation of hemostatic and structural properties of rehydrated lyophilised platelets: Potential for long-term storage of dried platelets for transfusion. Proc Natl Acad Sci U S A 1995, 92:397-401.
165. Bode A.P., Read M.S., Reddick R.L. Activation and adherence of lyophilized human platelets on canine vessel strips in the Baumgartner perfusion chamber 5. J Lab Clin Med 1999, 133:200-211.
166. Chao F.C., Kim B.K., Houranieh A.M., et al. Infusible platelet membrane microvesicles: A potential transfusion substitute for platelets. Transfusion 1996, 36:536-542.
167. Valeri C.R., MacGregor H., Barnard M.R., et al. Survival of baboon biotin-X-N-hydroxysuccinimide and (111)In-oxine-labelled autologous fresh and lyophilized reconstituted platelets. Vox Sanguinis 2005, 88:122-129.
168. Bode A.P., Lust R.M., Read M.S., et al. Correction of the bleeding time with lyophilized platelet infusion in dogs on cardiopulmonary bypass. Clin Appl Thrombosis/Hemostasis 2008, 14:38-54.
169. Fischer T., Merricks E., Raymer, et al. The coinfusion of rehydrated, lyophilized platelets with HBOC-201 for hemostasis in dilutional thrombocytopenia. Blood 2001, 98:225-234.
170. Hawksworth J.S., Elster E.A., Fryer D., et al. Evaluation of lyophilized platelets as an infusible hemostatic agent in experimental non-compressible hemorrhage in swine. J Thromb Haemost 2009, 7:1663-1671.
171. Fisher T.H., Bode A.P., Parker B.R., et al. Primary and secondary hemostatic functionalities of rehydrated, lyophilized platelets. Transfusion 2006, 46:1943-1950.
172. Goodrich R.P., Williams C.M., Franco R.S., et al. Lyophalization of red blood cells. US patent number 4,874,690. October 1989, 17.
173. Fisher T.H., Robbins M.E., Bode A.P., et al. Evidence that rehydrated, lyophilized red blood cells are sufficiently deformable for normal microcirculation transit. Microsc Res Tec 2004, 65:62-71.
174. Kheirolomoom A., Satpathy G.R., Török Z., et al. Phospholipid vesicles increase the survival of freeze-dried human red blood cells. Cryobiology 2005, 51:290-305.
175. Török Z., Satpathy G.R., Banerjee M., et al. Preservation of trehalose-loaded red blood cells by lyophilization. Cell Preserv Technol 2005, 3:96-111.
176. Brumfiel G. Just add water. Nature 2004, 428:14-15.
177. Millham F.H. A brief history of shock. Surgery 2010, 148:1026-1037.
178. Plurad D., Martin M., Green D., et al. The decreasing incidence of late posttraumatic acute respiratory distress syndrome: the potential role of lung protective ventilation and conservative transfusion practice. J Trauma 2007, 63:1-7.
179. Ling G.S., Rhee P., Ecklund J.M. Surgical innovations arising from the Iraq and Afghanistan wars. Annu Rev Med 2010, 61:457-468.